Barclays Maintains an 'Overweight' on AmerisourceBergen (ABC); Raising Estimates
Tweet
Share
E-mailGet Alerts ABC Hot Sheet
Price: $179.98 --0%
Rating Summary:
16 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 17
Rating Summary:
16 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 17
Join SI Premium – FREE
Barclays maintains an 'Overweight' on AmerisourceBergen (NYSE: ABC), PT $44.
Barclays analyst says, "After reviewing our ABC assumptions, we have raised our FY11 and FY12 estimates, taking FY11 EPS to $2.52 and FY12 EPS to $2.79. We believe we are on the way to another year of healthy upside for ABC, driven once again by a meaningful benefit from oxaliplatin. It appears that this product could generate another $100 million in profits to ABC this year after generating we estimate some $120 million in profits last year, representing what we believe have been 20%+ EBIT margins and representing an EPS contribution that has been 10% of total results these past two years, in our view. Quite impressive under any circumstances, but particularly when the product has not been available from any manufacturer since July 1 2010."
For more ratings news on AmerisourceBergen click here and for the rating history of AmerisourceBergen click here.
Shares of AmerisourceBergen closed at $42.03 yesterday.
Barclays analyst says, "After reviewing our ABC assumptions, we have raised our FY11 and FY12 estimates, taking FY11 EPS to $2.52 and FY12 EPS to $2.79. We believe we are on the way to another year of healthy upside for ABC, driven once again by a meaningful benefit from oxaliplatin. It appears that this product could generate another $100 million in profits to ABC this year after generating we estimate some $120 million in profits last year, representing what we believe have been 20%+ EBIT margins and representing an EPS contribution that has been 10% of total results these past two years, in our view. Quite impressive under any circumstances, but particularly when the product has not been available from any manufacturer since July 1 2010."
For more ratings news on AmerisourceBergen click here and for the rating history of AmerisourceBergen click here.
Shares of AmerisourceBergen closed at $42.03 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- HSBC Downgrades Feng Tay Enterprises (9910:TT) to Hold
- Westamerica Bancorp (WABC) PT Lowered to $50 at Piper Sandler
- CIMC Enric Holdings Ltd. (3899:HK) (CIMEF) PT Lowered to HK$8.70 at HSBC
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
BarclaysSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
